Q1 2026 Compass Pathways PLC Earnings Call Transcript

May 13, 2026 / 12:00 PM GMT

Release Date Price: $10.96 (+16.97%)

Transcript 8-K10-Q

Key Points

Positve

Compass Pathways PLC (CMPS) has demonstrated positive data from both Phase III studies, showing clinically meaningful efficacy for COMP360 in treatment-resistant depression (TRD).
The company has received a Commissioner's National Priority Voucher, which could accelerate the review timeline for COMP360's NDA submission.
Compass Pathways PLC (CMPS) is preparing for a potential accelerated launch of COMP360 by the end of the year, with strategic collaborations and commercial preparations underway.
The company has a strong balance sheet, with cash reserves expected to last beyond the launch and into 2028.
There is significant excitement and engagement from treatment centers and the VA for the potential of COMP360, indicating strong market interest and readiness for adoption.

Negative

The FDA's decision on whether to hold an advisory committee meeting for COMP360 is still uncertain, which could impact the review process.
There is no final determination on the release of long-term data from the 52-week study, which could be important for pricing and labeling discussions.
The reimbursement process for COMP360, including the transition from CPT-3 to CPT-1 codes, is still in progress and may affect provider adoption.
The DEA's rescheduling process for COMP360 remains sequential and could delay the timeline for federal approval and market entry.
The competitive landscape for psilocybin treatments is evolving, with other companies like Usona Institute also pursuing similar indications, which could impact market share.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CMPS.OQ - Compass Pathways PLC
Q1 2026 Compass Pathways PLC Earnings Call
May 13, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, ladies and gentlemen, and welcome to the Compass Pathways First Quarter Results Conference Call. At this time, all participants are in a listen-only mode. As a reminder, this call is being recorded. I would now like to introduce to you your host for today's call, Stephen Schultz. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Welcome, all of you, and thank you for joining us today for this conference call. I'm Steve Schultz, Senior Vice President, Investor Relations at Compass Pathways. And today, I'm joined by Kabir Nat, our Chief Executive Officer, and

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.